Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Lipedema Society (LS) is a national nonprofit public benefit corporation dedicated to advancing the clinical understanding, diagnosis, and treatment of lipedema and other fat disorders. Founded in 2015 by Dr. David Amron, the society focuses on raising awareness, providing medical education, and developing clinical guidance and standards of care. It operates as a multidisciplinary network of physicians and healthcare professionals, offering certification programs for surgeons and advocating for insurance reform. The organization translates research and real-world evidence into resources for patients, clinicians, and policymakers to improve the quality of care for those affected by lipedema. LS also sponsors a specialized surgical fellowship program to train qualified surgeons from around the world in advanced lipedema reduction techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipedema Society.